This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smith, C. Retroviral vector-mediated gene transfer into hematopoietic cells: Prospects and issues [ Review]. J. Hematother. 1, 155–166 (1992).
Brenner, M.K. Gene transfer to hematopoietic cells [Review]. N. Engl J. Med. 335, 337–339 (1996).
Kohn, D.B. et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017–1023 (1995).
Dunbar, C.E. et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048–3057 (1995).
Neering, S.J., Hardy, S.F., Minamoto, D., Spratt, S.K. & Jordan, C.T. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 88, 1147–1155 (1996).
Muench, M.O., Roncarolo, M.G., Namikawa, R., Barcena, A. & Moore, M.A. Progress in the ex vivo expansion of hematopoietic progenitors [Review]. Leuk. Lymphoma 16, 1–11 (1994).
Eipers, P.G. et al. Retroviral-mediated gene transfer in human bone marrow cells grown in continuous perfusion culture vessels. Blood 86, 3754–3762 (1995).
Bunnell, B.A., Muul, L.M., Donahue, R.E., Blaese, R.E. & Morgan, R.M. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl Acad. Sci. USA 92, 7739–7743 (1995).
Brenner, M.K. et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134–1137 (1993).
Lu, L., Xiao, M., Clapp, D.W., Li, Z.H. & Broxmeyer, H.E. High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J. Exp. Med. 178, 2089–2096 (1993).
Bagnis, C. et al. Retroviral transfer of the nlsLacZ gene into human CD34+ cell populations and into TF-1 cells: Future prospects in gene therapy. Hum. Gene Ther. 5, 1325–1333 (1994).
Fisher-Adams, G., Wong Jr., K.K., Podsakoff, G., Forman, S.J. & Chatterje, S. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 88, 492–504 (1996).
Conneally, E. et al. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 87, 456–464 (1996).
Mavilio, F. et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988–1997 (1994).
Medin, J.A. et al. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. Blood 87, 1754–1762 (1996).
Pawliuk, R., Kay, R., Lansdorp, P. & Humphries, R.K. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84, 2868–2877 (1994).
Planelles, V. et al. A new reporter system for detection of retroviral infection. Gene Ther. 2, 369–376 (1995).
Rudoll, T. et al. High efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T-lymphocytes. Gene Ther. 3, 695–705 (1996).
Sokolic, R. et al. A bicistronic retrovirus vector containing a picornovirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood 87, 42–50 (1996).
Tran, A.-C., Zhang, D., Byrn, R. & Roberts, M.P. Chimeric ζ-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes. J. Immunol. 155, 1000–1009 (1995).
Tumas, D.B., Spangrude, G.J., Brooks, D.M., Williams, C.D. & Chesebro, V. High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. Blood 87, 509–517 (1996).
Dwarki, V. et al. Gene therapy for hemophilia A: Production of therapeutic levels of human Factor VIII in vivo in mice. Proc. Natl. Acad. Sci. USA 92, 1023–1027 (1995).
Riviere, I., Brose, K. & Mulligan, R. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92, 6733–6737 (1995).
Cheng, L., Fu, J., Tsukamoto, A. & Hawley, R.G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnol. 14, 606–609 (1996).
Zolotukhin, S., Potter, M., Hauswirth, W.W., Guy, J. & Muzyczka, N. A “humanized” green fluorescent protein cDNA adapted for high level expression in mammalian cells. J. Virol. 70, 4646–4654 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Philips, K., Gentry, T., McCowage, G. et al. Cell–surface markers for assessing gene transfer into human hematopoietic cells. Nat Med 2, 1154–1156 (1996). https://doi.org/10.1038/nm1096-1154
Issue Date:
DOI: https://doi.org/10.1038/nm1096-1154
This article is cited by
-
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma
Cancer Gene Therapy (2007)
-
Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice
Leukemia (2000)
-
An in vitro system for efficiently evaluating gene therapy approaches to hemoglobinopathies
Gene Therapy (2000)
-
Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes
Gene Therapy (2000)
-
Immune response to green fluorescent protein: implications for gene therapy
Gene Therapy (1999)